In line with the efficiency of our system in down-regulating the hypoxia-responsive proteins including VEGF in cancer cells and its ability to reduce HIF-1α level via BRD4 depletion in zebrafish, we next evaluated the ENCTAC capacity in modulating angiogenesis, one typical hallmark of tumors. This evidence concerns the gene HIF1A and cancer.